Complementary dynamic BH3 profiles predict co-operativity between the multi-kinase inhibitor TG02 and the BH3 mimetic ABT-199 in acute myeloid leukaemia cells
about
Combined venetoclax and alvocidib in acute myeloid leukemia.Predicting effective pro-apoptotic anti-leukaemic drug combinations using co-operative dynamic BH3 profiling.CDK9 inhibitors in acute myeloid leukemia.Early changes in rpS6 phosphorylation and BH3 profiling predict response to chemotherapy in AML cells.
P2860
Complementary dynamic BH3 profiles predict co-operativity between the multi-kinase inhibitor TG02 and the BH3 mimetic ABT-199 in acute myeloid leukaemia cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Complementary dynamic BH3 prof ...... acute myeloid leukaemia cells
@en
Complementary dynamic BH3 prof ...... acute myeloid leukaemia cells.
@nl
type
label
Complementary dynamic BH3 prof ...... acute myeloid leukaemia cells
@en
Complementary dynamic BH3 prof ...... acute myeloid leukaemia cells.
@nl
prefLabel
Complementary dynamic BH3 prof ...... acute myeloid leukaemia cells
@en
Complementary dynamic BH3 prof ...... acute myeloid leukaemia cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
Complementary dynamic BH3 prof ...... acute myeloid leukaemia cells
@en
P2093
Amina Abdul-Aziz
Anthony Letai
Francis Burrows
Martin Grundy
Monica Pallis
Nigel Russell
P2860
P304
16220-16232
P356
10.18632/ONCOTARGET.8742
P407
P577
2017-03-01T00:00:00Z